Literature DB >> 19740328

Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells.

Jana Prochazkova1, Jan Fric, Katerina Pokorna, Ales Neuwirth, Magdalena Krulova, Alena Zajicova, Vladimir Holan.   

Abstract

The development and function of CD4(+) CD25(+) Foxp3(+) regulatory T cells (Tregs) are strictly regulated by cytokines. Here we show that transforming growth factor-beta (TGF-beta) and interleukin-4 (IL-4) play a crucial and antagonistic role in the development of Tregs. Additionally, these cytokines also have distinct effects on the maintenance of natural (nTregs) and antigen-induced (iTregs) Tregs. Using double-staining and tracking of proliferation of purified and carboxyflourescein succinimidyl ester (CFSE)-labelled mouse T-cell subpopulations we demonstrated that CD4(+) CD25(+) Foxp3(+) iTregs develop upon alloantigenic stimulation in the presence of TGF-beta exclusively from CD4(+) CD25(-) Foxp3(-) precursors. Both the induction of Foxp3 expression and Treg proliferation were prevented when the cells were stimulated in the presence of IL-4. By contrast, nTregs did not proliferate in the presence of the antigen and TGF-beta, and partially lost their Foxp3 expression. IL-4 not only prevented the development of iTregs, but also down-regulated the level of Foxp3 mRNA and decreased the number of Foxp3(+) cells in a population of iTregs. Further analyses proved that IL-4 decreased the expression of Foxp3 only in a population of iTregs, whereas it substantially supported the survival of nTregs. Functional experiments showed that Tregs induced in the presence of alloantigen and TGF-beta inhibited, on a per-cell basis, cell proliferation comparably to nTregs, and their suppressive capacity was not modulated by IL-4. These data suggest that TGF-beta and IL-4 differentially regulate the development of Tregs and distinctly sustain Foxp3 expression and the number of nTregs and iTregs, but have no influence on the suppressive activity of Tregs on a per-cell basis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740328      PMCID: PMC2753931          DOI: 10.1111/j.1365-2567.2009.03060.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

1.  IL-4 modulation of CD4+CD25+ T regulatory cell-mediated suppression.

Authors:  Luigia Pace; Claudio Pioli; Gino Doria
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

2.  Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism.

Authors:  W Ouyang; S H Ranganath; K Weindel; D Bhattacharya; T L Murphy; W C Sha; K M Murphy
Journal:  Immunity       Date:  1998-11       Impact factor: 31.745

3.  Production of high levels of Th1 and Th2 cytokines in mice with acquired transplantation tolerance.

Authors:  V Holán; K Sedlácková; M Růzicková
Journal:  Cell Immunol       Date:  1996-11-25       Impact factor: 4.868

4.  Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression.

Authors:  Byung-Min Choi; Hyun-Ock Pae; Young-Ran Jeong; Young-Myeong Kim; Hun-Taeg Chung
Journal:  Biochem Biophys Res Commun       Date:  2005-02-25       Impact factor: 3.575

5.  The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors.

Authors:  Alla Skapenko; Joachim R Kalden; Peter E Lipsky; Hendrik Schulze-Koops
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

6.  TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors.

Authors:  Shuang Fu; Nan Zhang; Adam C Yopp; Dongmei Chen; Minwei Mao; Dan Chen; Haojiang Zhang; Yaozhong Ding; Jonathan S Bromberg
Journal:  Am J Transplant       Date:  2004-10       Impact factor: 8.086

7.  Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta.

Authors:  H Suzuki; T M Kündig; C Furlonger; A Wakeham; E Timms; T Matsuyama; R Schmits; J J Simard; P S Ohashi; H Griesser
Journal:  Science       Date:  1995-06-09       Impact factor: 47.728

8.  TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells.

Authors:  Julien C Marie; John J Letterio; Marc Gavin; Alexander Y Rudensky
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

9.  Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization.

Authors:  Ruka Setoguchi; Shohei Hori; Takeshi Takahashi; Shimon Sakaguchi
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307

10.  CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.

Authors:  A M Thornton; E M Shevach
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  9 in total

1.  Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry.

Authors:  Lei Quan; Zhihong Gong; Song Yao; Elisa V Bandera; Gary Zirpoli; Helena Hwang; Michelle Roberts; Gregory Ciupak; Warren Davis; Lara Sucheston; Karen Pawlish; Dana H Bovbjerg; Lina Jandorf; Citadel Cabasag; Jean-Gabriel Coignet; Christine B Ambrosone; Chi-Chen Hong
Journal:  Int J Cancer       Date:  2013-10-08       Impact factor: 7.396

2.  Recipient myeloid-derived immunomodulatory cells induce PD-1 ligand-dependent donor CD4+Foxp3+ regulatory T cell proliferation and donor-recipient immune tolerance after murine nonmyeloablative bone marrow transplantation.

Authors:  Marie van der Merwe; Hossam A Abdelsamed; Aman Seth; Taren Ong; Peter Vogel; Asha B Pillai
Journal:  J Immunol       Date:  2013-11-04       Impact factor: 5.422

3.  The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population.

Authors:  Eliska Svobodova; Magdalena Krulova; Alena Zajicova; Katerina Pokorna; Jana Prochazkova; Peter Trosan; Vladimir Holan
Journal:  Stem Cells Dev       Date:  2011-07-26       Impact factor: 3.272

4.  Impact of developmental lead exposure on splenic factors.

Authors:  Jane Kasten-Jolly; Yong Heo; David A Lawrence
Journal:  Toxicol Appl Pharmacol       Date:  2010-06-11       Impact factor: 4.219

5.  Nonredundant roles of IL-10 and TGF-β in suppression of immune responses to hepatic AAV-factor IX gene transfer.

Authors:  Brad E Hoffman; Ashley T Martino; Brandon K Sack; Ou Cao; Gongxian Liao; Cox Terhorst; Roland W Herzog
Journal:  Mol Ther       Date:  2011-03-08       Impact factor: 11.454

6.  Activation-induced FoxP3 expression regulates cytokine production in conventional T cells stimulated with autologous dendritic cells.

Authors:  Derek J Cavatorta; Hollis N Erb; M Julia Felippe
Journal:  Clin Vaccine Immunol       Date:  2012-08-01

Review 7.  The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung.

Authors:  Florian Wirsdörfer; Verena Jendrossek
Journal:  Front Immunol       Date:  2016-12-14       Impact factor: 7.561

8.  Interleukin-4 Supports the Suppressive Immune Responses Elicited by Regulatory T Cells.

Authors:  Wei-Cheng Yang; Yih-Shiou Hwang; Ying-Yu Chen; Chao-Lin Liu; Chia-Ning Shen; Wei-Hsin Hong; Sheng-Min Lo; Chia-Rui Shen
Journal:  Front Immunol       Date:  2017-11-14       Impact factor: 7.561

Review 9.  The CD73/Ado System-A New Player in RT Induced Adverse Late Effects.

Authors:  Simone de Leve; Florian Wirsdörfer; Verena Jendrossek
Journal:  Cancers (Basel)       Date:  2019-10-16       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.